Cancer Research

Following the launch of its limited edition PIPETGIRL pink pipette controller in support of breast cancer research earlier this year - INTEGRA is pleased to announce it has made a $10,000 contribution to the Susan F. Smith Center for Women’s Cancers at Dana-Farber Cancer Institute in Boston (MA, USA).

$1 billion will create first large-scale program to overhaul early detection of lethal cancers
Fast-track recruitment of 250-300 scientists set to launch.

The vast majority of the thousands of chemicals in our homes and workplaces have not been tested to determine if they cause cancer. That’s because today’s options are lacking. Rodent tests are too slow, and cell culture tests don’t replicate how cells interact in the body, so their relevance to cancer is limited. Scientists from the U.S. Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) have set out to change that.














